(Q36379346)

13 August 2017

1 reference

title

Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children (English)

1 reference

methicillin-resistant Staphylococcus aureus

13 August 2017

0 references

Staphylococcus aureus

1 reference

John F Marcinak

1

1 reference

PubMed ID

16441212

13 August 2017

Arthur L Frank

series ordinal

2

1 reference

13 August 2017

1 February 2006

1 reference

Expert Review of Anti-infective Therapy

13 August 2017

1 reference

13 August 2017

4

1 reference

13 August 2017

1

1 reference

13 August 2017

91-100

1 reference

Epidemic community-associated methicillin-resistant Staphylococcus aureus: modern times for an ancient pathogen

13 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Community-associated methicillin-resistant Staphylococcus aureus: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Three-year surveillance of community-acquired Staphylococcus aureus infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Exponential increase in community-acquired methicillin-resistant Staphylococcus aureus infections in South Texas children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Community-acquired methicillin-resistant Staphylococcus aureus in southern New England children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Epidemiology of methicillin-resistant Staphylococcus aureus at a children's hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Epidemiological typing of community-acquired methicillin-resistant Staphylococcus aureus isolates from children in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

A clone of methicillin-resistant Staphylococcus aureus among professional football players.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Methicillin-resistant Staphylococcus aureus disease in three communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Emergence of community-acquired methicillin-resistant Staphylococcus aureus in complicated parapneumonic effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Severe Staphylococcus aureus Infections Caused by Clonally Related Community-Acquired Methicillin-Susceptible and Methicillin-Resistant Isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Community-associated MRSA--resistance and virulence converge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Community-associated methicillin-resistant Staphylococcus aureus in hospital nursery and maternity units

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

The association between Staphylococcus aureus strains carrying panton-valentine leukocidin genes and the development of deep-seated follicular infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Treatment of community-associated methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Community-Acquired Methicillin-Resistant Staphylococcus aureus in Children and Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Selection of strains for quality assessment of the disk induction method for detection of inducible clindamycin resistance in Staphylococci: a CLSI collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Influences of Linezolid, Penicillin, and Clindamycin, Alone and in Combination, on Streptococcal Pyrogenic Exotoxin A Release

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Appropriate antimicrobial therapy for community-acquired methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Acute osteomyelitis and septic arthritis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Successful outpatient treatment of sinusitis exacerbations caused by community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Tigecycline: a new glycylcycline for treatment of serious infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

Telithromycin: a ketolide antibiotic for treatment of respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.1.91

21 January 2018

Identifiers

DOI

10.1586/14787210.4.1.91

1 reference

13 August 2017

1 reference

PubMed ID

16441212